Theseus Pharmaceuticals Inc (DELISTED) (THRX:DL)
4.06
0.00 (0.00%)
USD |
NASDAQ |
Feb 23, 16:00
Theseus Pharmaceuticals Total Assets (Quarterly): 234.63M for Sept. 30, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 234.63M |
| June 30, 2023 | 245.07M |
| March 31, 2023 | 255.62M |
| December 31, 2022 | 222.45M |
| September 30, 2022 | 230.29M |
| June 30, 2022 | 238.29M |
| Date | Value |
|---|---|
| March 31, 2022 | 247.50M |
| December 31, 2021 | 250.93M |
| September 30, 2021 | 97.62M |
| June 30, 2021 | 102.07M |
| December 31, 2020 | 8.614M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
8.614M
Minimum
Dec 2020
255.62M
Maximum
Mar 2023
193.92M
Average
234.63M
Median
Sep 2023
Total Assets (Quarterly) Benchmarks
| Karuna Therapeutics Inc (DELISTED) | 1.336B |
| NovaBay Pharmaceuticals Inc | 5.357M |
| Palatin Technologies Inc | 11.41M |
| iBio Inc | 50.15M |
| Theriva Biologics Inc | 48.73M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 10.10M |
| Shareholders Equity (Quarterly) | 224.52M |